Sight Sciences, Inc. (SGHT)
8.28
-0.52
(-5.91%)
USD |
NASDAQ |
Oct 16, 16:00
8.295
+0.02
(+0.18%)
After-Hours: 20:00
Sight Sciences Research and Development Expense (Annual) : 14.61M for Dec. 31, 2025
Research and Development Expense (Annual) Chart
Historical Research and Development Expense (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | 14.61M |
| December 31, 2024 | 17.99M |
| December 31, 2023 | 17.56M |
| December 31, 2022 | 22.86M |
| Date | Value |
|---|---|
| December 31, 2021 | 15.63M |
| December 31, 2020 | 9.174M |
| December 31, 2019 | 8.124M |
| December 31, 2018 | 5.426M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Annual) Benchmarks
| Integra LifeSciences Holdings Corp. | 34.81M |
| Abbott Laboratories | 2.889B |
| AngioDynamics, Inc. | 29.45M |
| Alphatec Holdings, Inc. | 76.27M |
| AtriCure, Inc. | 90.17M |